Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
ICL · NYSE · United States · Agricultural Chemicals
In shortICL Group Ltd. is profitable, generates cash and carries moderate debt, with revenue growing (+4.6% last year).
Financial health
Mixed
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 8.1% | 44/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 3.2% | 33/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 3.9% | 19/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 4.4% | 30/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.33× | 44/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.39× | 90/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.55× | 70/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 1.95× | 4/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | – | n/a |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 14.8% | 79/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 4.67× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 29.8% | 1/100 |
| Operating margin volatility | 10.5% | 14/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -10.6% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | -52.4% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 6,955 | 10,015 | 7,536 | 6,841 | 7,153 |
| Cost of revenue | 4,344 | 4,983 | 4,865 | 4,585 | 4,967 |
| Gross profit | 2,611 | 5,032 | 2,671 | 2,256 | 2,186 |
| Research & development | 64 | 68 | 71 | 69 | 70 |
| Operating income | 1,210 | 3,516 | 1,141 | 775 | 580 |
| Interest expense | 216 | 327 | 259 | 181 | 298 |
| Pre-tax income | 1,092 | 3,404 | 974 | 636 | 441 |
| Income tax | 260 | 1,185 | 287 | 172 | 161 |
| Net income | 783 | 2,159 | 647 | 407 | 226 |
| Diluted EPS | $0.60 | $1.67 | $0.50 | $0.32 | $0.18 |
| Diluted shares (millions) | 1,287 | 1,290 | 1,291 | 1,290 | 1,291 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: a required balance-sheet item is missing.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Mar 11, 2026